Cerenome (PSTV) Cash from Operations (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Cash from Operations of 6238000.0 for Q1 2026, down 1.07% year-over-year from 6305426.79 in Q1 2025, and up 0.59% quarter-over-quarter from 6275000.0 in Q4 2025.
Cerenome (PSTV) Cash from Operations (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Cash from Operations for 17 consecutive years, with 6238000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 1.07% year-over-year to 6238000.0; the TTM figure through Mar 2026 stood at 20841000.0 (down 70.65% YoY), while the FY2025 annual figure was 20775000.0, down 96.84% from the prior year.
- Cash from Operations grew to 6238000.0 in Q1 2026 per PSTV's latest filing, from 6275000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1150000.0 in Q2 2024 and bottomed at 6275000.0 in Q4 2025.
- Historically, Cash from Operations has averaged 3728823.53 across 5 years, with a median of 3680000.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Operations surged 58.6% — and 2025, when it tumbled 418.17%.
- Plus Therapeutics' Cash from Operations stood at 2234000.0 in 2022, then grew by 15.8% to 1881000.0 in 2023, then surged by 35.62% to 1211000.0 in 2024, then sank by 418.17% to 6275000.0 in 2025, then climbed by 0.59% to 6238000.0 in 2026.
- Business Quant data shows PSTV's Cash from Operations at 6238000.0 in Q1 2026, 6275000.0 in Q4 2025, and 2530000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | -7.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.24 Mn |
| Mar 31, 2026 | -6.24 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -2.53 Mn |
| Sep 30, 2025 | -2.53 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -3.68 Mn |
| Sep 30, 2024 | -3.68 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | -4.51 Mn |
| Mar 31, 2024 | -4.51 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Dec 31, 2023 | -1.88 Mn |